Bactiguard Holding AB (publ) (STO:BACTI.B)

Market Cap	1.03B
Revenue (ttm)	247.63M
Net Income (ttm)	-24.64M
Shares Out	35.04M
EPS (ttm)	-0.70
PE Ratio	n/a
Forward PE	85.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37
Average Volume	4,804
Open	29.60
Previous Close	29.10
Day's Range	29.10 - 29.60
52-Week Range	22.20 - 76.40
Beta	0.53
RSI	45.01
Earnings Date	Apr 17, 2025

About Bactiguard Holding AB

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management products, such as Hydrocyn Aqua,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 177
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BACTI.B

Financial Performance

In 2024, Bactiguard Holding AB's revenue was 243.68 million, an increase of 19.46% compared to the previous year's 203.99 million. Losses were -29.82 million, -78.45% less than in 2023.